Biosimilars and Health Economics

Biopharmaceuticals also known as biologic drugs or biologics, are pharmaceutical products derived from biological sources, such as living cells or organisms. They are produced using biotechnology techniques and typically consist of large, complex molecules, such as proteins, peptides, antibodies, nucleic acids, or living microorganisms.

Biopharmaceuticals have revolutionized the field of medicine by offering innovative treatment options for various diseases, including cancer, autoimmune disorders, hormonal imbalances, genetic diseases, and more. They are designed to target specific molecules or pathways involved in disease processes, providing highly targeted and personalized therapies

    Related Conference of Biosimilars and Health Economics

    June 13-14, 2024

    30th Asia Pacific Biotechnology Congress

    Dubai, UAE
    July 11-12, 2024

    6th International Conference on Biochemistry

    Paris, France
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France
    October 03-04, 2024

    15th International Conference on Biofuels and Bioenergy

    Singapore City, Singapore
    December 12-13, 2024

    15th World Congress on Cell & Tissue Science

    Rome, Italy

    Biosimilars and Health Economics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in